Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniae
Abstract
Candida lusitaniae is an important nosocomial pathogen that may express resistance to one or more antifungal agents including amphotericin B. We investigated the genotypic diversity and antifungal susceptibility among 47 clinical isolates from 33 patients hospitalized in 12 different medical centers. Strain delineation was performed by restriction endonuclease analysis of genomic DNA (REAG) with the restriction enzyme Sfi I followed by pulsed-field gel electrophoresis and by electrophoretic karyotyping (EK). Antifungal susceptibility of the isolates to amphotericin B, 5-fluorocytosine (5FC), fluconazole, and itraconazole was determined using National Committee for Clinical Laboratory Standards standard methods. Minimum inhibitory concentration (MIC)90 values ranged from 0.5 micrograms/ml for itraconazole to 512 micrograms/ml for 5FC. In general, isolates from a given patient or epidemiologically related isolates from a nosocomial cluster were identical by molecular typing methods. Epidemiologically unrelated isolates were all distinctly different by both EK and REAG typing methods. Although elevated amphotericin B MICs ( > or = 2 micrograms/ml) were observed in only three isolates, extended incubation (72 h) revealed amphotericin B MICs of 2-16 micrograms/ml in a subset of isolates suggesting potential amphotericin B resistance. These data document the genetic diversity, nosocomial transmission, and antifungal susceptibility of clinical isolates of C. lusitaniae.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Not all C. lusitaniae isolates are resistant, but therapeutic failure of amphotericin B is well documented.
“Not all isolates are resistant [11,23,37], but therapeutic failure of amphotericin B is well documented [38].”
From Guidelines for Treatment of Candidiasis (2004) · cites this paper as [23]
In virtually every U.S.-based survey, C. glabrata ranks second to C. albicans as a cause of BSI, accounting for 20% to 24% of all Candida BSIs.
“and virtually every U.S.-based survey has shown C. glabrata to rank second to C. albicans as a cause of BSI, accounting for 20% to 24% of all Candida BSIs (Table 8) (57, 92, 113, 145, 146, 183, 188, 205, 207-209, 212, 216, 220, 224, 292).”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [208]
Several studies have documented a significant trend toward an increased proportion of BSI due to C. glabrata with increasing patient age.
“Several studies have now documented a significant trend toward an increased proportion of BSI due to C. glabrata with increasing patient age (Table 9 and Fig. 2) (23, 57, 90, 125, 145, 146, 188, 208, 209, 259).”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [208]
Cites
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,435 · see citing works
Manual of Clinical Microbiology
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-3-239_2 · Cited by 987 · see citing works
Antifungal susceptibility testing
Rex, J. H., Pfaller, M. A., Rinaldi, M. G., Polak, A., & Galgiani, J. N. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.4.367 · Cited by 361 · see citing works
Lehmann, P. F., Lin, D., & Lasker, B. A. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.12.3249-3254.1992 · Cited by 259 · see citing works
Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis
Branchini, M. L. M., Pfaller, M. A., Rhine-Chalberg, J., Frempong, T. A., & Isenberg, H. D. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.2.452-456.1994 · Cited by 242 · see citing works
Investigation of the sequence of colonization and candidemia in nonneutropenic patients
Voss, A., Hollis, R. J., Pfaller, M. A., Wenzel, R. P., & Doebbeling, B. N. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.4.975-980.1994 · Cited by 226 · see citing works
Haley, L. D. (1961) · American Journal of Clinical Pathology · doi:10.1093/ajcp/36.3.227 · Cited by 216 · see citing works
Pfaller, M. A., Rhine-Chalberg, J., Redding, S. W., Smith, J. D., Farinacci, G. C., Fothergill, A. W., & Rinaldi, M. G. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.1.59-64.1994 · Cited by 197 · see citing works
Development of Resistance to Amphotericin B in Candida lusitaniae Infecting a Human
Pappagianis, D., Collins, M., Hector, R., & Remington, J. S. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.16.2.123 · Cited by 182 · see citing works
Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance
Merz, W. G. (1984) · Journal of Clinical Microbiology · doi:10.1128/jcm.20.6.1194-1195.1984 · Cited by 167 · see citing works
Pfaller, M. A., & Barry, A. L. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.8.1992-1996.1994 · Cited by 160 · see citing works
Epidemiology and Control of Fungal Infections
Pfaller, M. A. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.supplement_1.s8 · Cited by 149 · see citing works
Mycoses Caused by Candida lusitaniae
Hadfield, T. L., Smith, M. B. H., Winn, R. E., Rinaldi, M. G., & Guerra, C. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.5.1006 · Cited by 139 · see citing works
Emergence of a new opportunistic pathogen, Candida lusitaniae
Blinkhorn, R. J., Adelstein, D. J., & Spagnuolo, P. J. (1989) · Journal of Clinical Microbiology · doi:10.1128/jcm.27.2.236-240.1989 · Cited by 129 · see citing works
Candida albicans strain delineation
Merz, W. G. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.4.321 · Cited by 126 · see citing works
Fatal septicemia due to amphotericin B-resistant Candida lusitaniae
Guinet, R., Chanas, J., Goullier, A., Bonnefoy, G., & Ambroise-Thomas, P. (1983) · Journal of Clinical Microbiology · doi:10.1128/jcm.18.2.443-444.1983 · Cited by 125 · see citing works
Pfaller, M. A., Grant, C., Morthland, V. H., & Rhine-Chalberg, J. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.2.506-509.1994 · Cited by 123 · see citing works
Epidemiology of nosocomial acquisition of Candida lusitaniae
Sánchez, V., Vázquez, J. A., Barth-Jones, D. C., Dembry, L., Sobel, J. D., & Zervos, M. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.11.3005-3008.1992 · Cited by 97 · see citing works
Vázquez, J. A., Beckley, A., Donabedian, S. M., Sobel, J. D., & Zervos, M. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.8.2021-2030.1993 · Cited by 74 · see citing works
Epidemiological Typing Methods for Mycoses
Pfaller, M. A. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.supplement_1.s4 · Cited by 71 · see citing works
Doebbeling, B. N., Lehmann, P. F., Hollis, R. J., Wu, L.-C., Widmer, A. F., Voss, A., & Pfaller, M. A. (1993) · Clinical Infectious Diseases · doi:10.1093/clind/16.3.377 · Cited by 67 · see citing works
Pfaller, M. A., Vũ, Q. D., Lancaster, M., Espinel‐Ingroff, A., Fothergill, A. W., Grant, C., McGinnis, M. R., Pasarell, L., Rinaldi, M. G., & Steele‐Moore, L. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.7.1625-1628.1994 · Cited by 65 · see citing works
Pfaller, M. A., Bale, M. J., Buschelman, B. J., Lancaster, M., Espinel-Ingroff, A. V., Rex, J. H., & Rinaldi, M. G. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.7.1650-1653.1994 · Cited by 59 · see citing works
Strain delineation and epidemiology of Candida (Clavispora) lusitaniae
Merz, W. G., Khazan, U., Jabra‐Rizk, M. A., Wu, L. C., Osterhout, G., & Lehmann, P. F. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.2.449-454.1992 · Cited by 53 · see citing works
Christenson, J. C., Guruswamy, A. P., Mukwaya, G., & RETTING, P. J. (1987) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198708000-00013 · Cited by 47 · see citing works
Pfaller, M. A., Buschelman, B. J., Bale, M. J., Lancaster, M. V., Espinel‐Ingroff, A., Rex, J. H., & Rinaldi, M. G. (1994) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(94)90044-2 · Cited by 33 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · see citing works
Guidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440 · see citing works
Practice Guidelines for the Treatment of Candidiasis
Rex, J. H., Walsh, T. J., Sobel, J. D., Filler, S. G., Pappas, P. G., Dismukes, W. E., & Edwards, J. E. (2000) · Clinical Infectious Diseases · doi:10.1086/313749 · Cited by 927 · see citing works
Resistance to Antifungal Agents: Mechanisms and Clinical Impact
Kanafani, Z. A., & Perfect, J. R. (2008) · Clinical Infectious Diseases · doi:10.1086/524071 · Cited by 619 · see citing works
Nosocomial Candidiasis: Emerging Species, Reservoirs, and Modes of Transmission
Pfaller, M. A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.supplement_2.s89 · Cited by 499 · see citing works
Antifungal agents: chemotherapeutic targets and immunologic strategies
Georgopapadakou, N. H., & Walsh, T. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.279 · Cited by 495 · see citing works
Epidemiology of invasive candidiasis
Arendrup, M. C. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32833e84d2 · Cited by 376 · see citing works
Groll, A. H., Piscitelli, S. C., & Walsh, T. J. (1998) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60129-5 · Cited by 377 · see citing works
The Ins and Outs of DNA Fingerprinting the Infectious Fungi
Soll, D. R. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.2.332-370.2000 · Cited by 348 · see citing works
Current Treatment Strategies for Disseminated Candidiasis
Spellberg, B. J., Filler, S. G., & Edwards, J. E. (2005) · Clinical Infectious Diseases · doi:10.1086/499057 · Cited by 253 · see citing works
Nosocomial fungal infections: candidemia
Lunel, F. M. V., Meis, J. F. G. M., & Voß, A. (1999) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00035-8 · Cited by 168 · see citing works
Pfaller, M. A., Diekema, D. J., Messer, S. A., Boyken, L. B., Hollis, R. J., & Jones, R. N. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.78-83.2003 · Cited by 165 · see citing works
Secular Trends of Candidemia Over 12 Years in Adult Patients at a Tertiary Care Hospital
GARBINO, J., KOLAROVA, L., ROHNER, P., LEW, D., PICHNA, P., & PITTET, D. (2002) · Medicine · doi:10.1097/00005792-200211000-00003 · Cited by 143 · see citing works
Diekema, D. J., Messer, S. A., Boyken, L. B., Hollis, R. J., Kroeger, J. S., Tendolkar, S., & Pfaller, M. A. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00942-09 · Cited by 125 · see citing works
Antifungal drug resistance mechanisms
Pemán, J., Cantón, E., & Espinel‐Ingroff, A. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.18 · Cited by 121 · see citing works
Patterns of Amphotericin B Killing Kinetics against Seven Candida Species
Cantón, E., Pemán, J., Gobernado, M., Viudes, A., & Espinel‐Ingroff, A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2477-2482.2004 · Cited by 119 · see citing works
Takakura, S. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh053 · Cited by 117 · see citing works
Antifungal agents of use in animal health – chemical, biochemical and pharmacological aspects
BOSSCHE, H. V., Engelen, M., & Rochette, F. (2003) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1046/j.1365-2885.2003.00456.x · Cited by 107 · see citing works
Godoy, P., Tiraboschi, I. N., Severo, L. C., Bustamante, B., Calvo, B., de Almeida, L. P., da Matta, D. A., & Colombo, A. L. (2003) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762003000300020 · Cited by 102 · see citing works
Challenges in the Polyene- and Azole-Based Pharmacotherapy of Ocular Fungal Infections
Lakhani, P. M., Patil, A., & Majumdar, S. (2018) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2018.0089 · Cited by 102 · see citing works
Genetic diversity of medically important and emerging Candida species causing invasive infection
Merseguel, K. B., Nishikaku, A. S., Rodrigues, A. M., Padovan, A. C. B., Ferreira, R. C., Melo, A. S. D. A., Briones, M. R. S., & Colombo, A. L. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0793-3 · Cited by 101 · see citing works
Candida lusitaniae: A Cause of Breakthrough Fungemia in Cancer Patients
Minari, A., Hachem, R., & Raad, I. (2001) · Clinical Infectious Diseases · doi:10.1086/318473 · Cited by 96 · see citing works
Yoon, S. A., Vázquez, J. A., Steffan, P. E., Sobel, J. D., & Akins, R. A. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.836 · Cited by 90 · see citing works
Improved Detection of Amphotericin B-Resistant Isolates of <i>Candida lusitaniae</i> by Etest
Peyron, F., Favel, A., Michel-Nguyen, A., Gilly, M., Regli, P., & Bolmström, A. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.1.339-342.2001 · Cited by 87 · see citing works
Hull, C. M., Bader, O., Parker, J. E., Weig, M., Gross, U., Warrilow, A. G. S., Kelly, D. E., & Kelly, S. L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01145-12 · Cited by 90 · see citing works
Nosocomial fungaemia: a 2-year prospective study
Costa, S. F., Marinho, I. S., de Araújo, E. S. A., Manrique, A. E. I., & Levin, A. S. (2000) · Journal of Hospital Infection · doi:10.1053/jhin.1999.0670 · Cited by 81 · see citing works
Clinical relevance of mechanisms of antifungal drug resistance in yeasts
Sanglard, D. (2002) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(02)72842-5 · Cited by 79 · see citing works
Pharmacokinetics and Pharmacodynamics of Antifungals in Children: Clinical Implications
Autmizguine, J., Guptill, J. T., Cohen‐Wolkowiez, M., Benjamin, D. K., & Capparelli, E. V. (2014) · Drugs · doi:10.1007/s40265-014-0227-3 · Cited by 75 · see citing works
Overview of treatment options for invasive fungal infections
Pound, M. W., Townsend, M. L., DiMondi, V. P., Wilson, D. T., & Drew, R. H. (2011) · Medical Mycology · doi:10.3109/13693786.2011.560197 · Cited by 69 · see citing works
Favel, A., Michel-Nguyen, A., Peyron, F., Martin, C., Thomachot, L., Datry, A., Bouchara, J., Challier, S., Noël, T., Chastin, C., et al. (2003) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(03)00094-4 · Cited by 67 · see citing works
Standardization of antifungal susceptibility testing
Cormican, M., & Pfaller, M. A. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.4.561 · Cited by 63 · see citing works
Shibata, N., Kobayashi, H., Okawa, Y., & Suzuki, S. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03622.x · Cited by 53 · see citing works
Costa, C. R., Lemos, J. A., Passos, X. S., de Araújo, C. R., Cohen, A. J., Souza, L. K. H. E., & Silva, M. D. R. R. (2006) · Mycopathologia · doi:10.1007/s11046-006-0032-y · Cited by 52 · see citing works
Ernst, E. J., Yodoi, K., Roling, E. E., & Klepser, M. E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.578-581.2002 · Cited by 52 · see citing works
Florent, M., Noël, T., Ruprich‐Robert, G., Silva, B. D., Fitton‐Ouhabi, V., Chastin, C., Papon, N., & Chapeland‐Leclerc, F. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00880-08 · Cited by 50 · see citing works
Chapeland-Leclerc, F., Bouchoux, J., Goumar, A., Chastin, C., Villard, J., & Noël, T. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3101-3108.2005 · Cited by 48 · see citing works
Lischewski, A., Amann, R., Harmsen, D., Merkert, H., Hacker, J. H., & Morschhäuser, J. (1996) · Microbiology · doi:10.1099/13500872-142-10-2731 · Cited by 47 · see citing works
Species diversity of yeast in oral colonization of insulin-treated diabetes mellitus patients
Pires, R. H., Miranda, E. T., Zaia, J. E., & Mendes‐Giannini, M. J. S. (2006) · Mycopathologia · doi:10.1007/s11046-006-0038-5 · Cited by 46 · see citing works
Strain variation among and antifungal susceptibilities of isolates of Candida krusei
Berrouane, Y., Hollis, R. J., & Pfaller, M. A. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.7.1856-1858.1996 · Cited by 44 · see citing works
Evidence for Person-to-Person Transmission of Candida lusitaniae in a Neonatal Intensive-Care Unit
Fowler, S. L., Rhoton, B., Springer, S. C., Messer, S. A., Hollis, R. J., & Pfaller, M. A. (1998) · Infection Control and Hospital Epidemiology · doi:10.2307/30141376 · Cited by 40 · see citing works
McClenny, N. B., Fei, H., Baron, E. J., Gales, A. C., Houston, A., Hollis, R. J., & Pfaller, M. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1325-1328.2002 · Cited by 39 · see citing works
François, F., Noël, T., Pépin, R., Brulfert, A., Chastin, C., Favel, A., & Villard, J.-F. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.11.3906-3914.2001 · Cited by 38 · see citing works
Lischewski, A., Kretschmar, M., Hof, H., Amann, R., Hacker, J. H., & Morschhäuser, J. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.11.2943-2948.1997 · Cited by 37 · see citing works
Evaluation of DNA-based typing procedures for strain categorization of Candida spp.
Espinel‐Ingroff, A., Vázquez, J. A., Boikov, D. A., & Pfaller, M. A. (1999) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00143-6 · Cited by 34 · see citing works
The Epidemiology of Invasive Candidiasis
Pfaller, M. A., & Diekema, D. J. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch29 · Cited by 33 · see citing works
Boisnard, S., Ruprich‐Robert, G., Florent, M., Silva, B. D., Chapeland‐Leclerc, F., & Papon, N. (2008) · Yeast · doi:10.1002/yea.1636 · Cited by 32 · see citing works
Pinto, P. M., de Resende, M. A., Koga‐Ito, C. Y., & Tendler, M. (2004) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762004000200006 · Cited by 32 · see citing works
Khan, Z., Ahmad, S., Al‐Obaid, I., Al‐Sweih, N., Joseph, L., & Farhat, D. (2008) · Journal of Chemotherapy · doi:10.1179/joc.2008.20.4.488 · Cited by 31 · see citing works
Manfredi, M., McCullough, M. J., Polonelli, L., Conti, S., Al‐Karaawi, Z. M., Vescovi, P., & Porter, S. R. (2006) · Oral Microbiology and Immunology · doi:10.1111/j.1399-302x.2006.00274.x · Cited by 31 · see citing works
François, F., Chapeland‐Leclerc, F., Villard, J.-F., & Noël, T. (2003) · Yeast · doi:10.1002/yea.1059 · Cited by 30 · see citing works
Viscoli, C., & Castagnola, E. (1999) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(99)90019-x · Cited by 29 · see citing works
Chapeland‐Leclerc, F., Paccallet, P., Ruprich‐Robert, G., Reboutier, D., Chastin, C., & Papon, N. (2007) · Eukaryotic Cell · doi:10.1128/ec.00155-07 · Cited by 28 · see citing works
Miguel, L. G. S., Plá, J., Cobo, J., Navarro, F., Sánchez-Sousa, A., Alvarez, M. E., Martos, I., & Moreno, S. (2004) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.03.017 · Cited by 28 · see citing works
Scott, N. E., Erayil, S. E., Kline, S. E., & Selmecki, A. M. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00543-23 · Cited by 25 · see citing works
Candidemia in the in-patient setting: treatment options and economics
Gagne, J. J., & Goldfarb, N. I. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.11.1643 · Cited by 27 · see citing works
Mechanisms of Antifungal Drug Resistance in Candida Dubliniensis
Coleman, D. C., Moran, G. P., McManus, B. A., & Sullivan, D. J. (2010) · Future Microbiology · doi:10.2217/fmb.10.51 · Cited by 27 · see citing works
In-vitro susceptibility pattern of Candida lusitaniae and evaluation of the Etest method
Favel, A. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/39.5.591 · Cited by 26 · see citing works
Ruprich‐Robert, G., Chapeland‐Leclerc, F., Boisnard, S., Florent, M., Bories, G. F. P., & Papon, N. (2008) · Eukaryotic Cell · doi:10.1128/ec.00066-08 · Cited by 24 · see citing works
Evidence for Person-to-Person Transmission of Candida lusitaniae in a Neonatal Intensive-Care Unit
Fowler, S. L., Rhoton, B., Springer, S. C., Messer, S. A., Hollis, R. J., & Pfaller, M. A. (1998) · Infection Control and Hospital Epidemiology · doi:10.1086/647826 · Cited by 24 · see citing works
Favel, A. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.2.227 · Cited by 23 · see citing works
Metin, D. Y., Polat, S. H., Şamlıoğlu, P., Doganay-Oflazoglu, B., İnci, R., & Tümbay, E. (2011) · Mycopathologia · doi:10.1007/s11046-011-9413-y · Cited by 22 · see citing works
Reboutier, D., Piednoël, M., Boisnard, S., Conti, A., Chevalier, V., Florent, M., Gibot‐Leclerc, S., Silva, B. D., Chastin, C., Fallague, K., et al. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.10.019 · Cited by 20 · see citing works
Sterol and Fatty Acid Composition ofCandida lusitaniaeClinical Isolates
Peyron, F., Favel, A., Calaf, R., Michel-Nguyen, A., Bonaly, R., & Coulon, J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.531-533.2002 · Cited by 18 · see citing works
Eletroforese em campo pulsante em bacteriologia - uma revisão técnica
Magalhães, V. D., Ferreira, J. C., Barelli, C., & Darini, A. L. D. C. (2005) · REVISTA DO INSTITUTO ADOLFO LUTZ · doi:10.53393/rial.2005.64.32977 · Cited by 16 · see citing works
Emerging issues in nosocomial fungal infections
Toscano, C. M., & Jarvis, W. R. (1999) · Current Infectious Disease Reports · doi:10.1007/s11908-999-0041-3 · Cited by 16 · see citing works
Exploration of Medicinal Plants as Sources of Novel Anticandidal Drugs
Kumar, A., Khan, F., & Saikia, D. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666191025155856 · Cited by 12 · see citing works
Singh, J., Rimek, D., & Kappe, R. (2006) · Mycoses · doi:10.1111/j.1439-0507.2006.01197.x · Cited by 13 · see citing works
Traitement antifongique des candidoses systémiques en réanimation
Kettani, A., Belkhadir, Z. H., Mosadik, A., Faroudy, M., Ababou, A., Lazreq, C., & Sbihi, A. (2006) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2005.10.004 · Cited by 12 · see citing works
Turan, Ö., Ergenekon, E., Hirfanoğlu, İ. M., Önal, E. E., Vn, B., Türkyılmaz, C., Koç, E., & Atalay, Y. (2011) · PubMed · Cited by 11 · see citing works
Prolonged growth of Candida albicans reveals co-isolated bacteria from single yeast colonies
Bruno, D. D. C. F., Bartelli, T. F., Rodrigues, C. R., & Briones, M. R. S. (2018) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2018.07.021 · Cited by 10 · see citing works
The Molecular Epidemiology of Nosocomial Infection
Goering, R. V. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46807-7_9 · Cited by 9 · see citing works
Heterogeneity of Candida bloodstream isolates in an academic medical center and affiliated hospitals
Scott, N. E., Wash, E., Zajac, C., Erayil, S. E., Kline, S. E., & Selmecki, A. M. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.00464-25 · Cited by 6 · see citing works
Hamal, P., Hanzen, J., Horn, F., Trtkova, J., Ruskova, L., Večeřová, R., Růžička, F., Volleková, A., & Raclavský, V. (2011) · Folia Microbiologica · doi:10.1007/s12223-011-0063-8 · Cited by 7 · see citing works
Antifungal and Antiviral Therapy
Ostrosky‐Zeichner, L., & Rex, J. H. (2008) · Elsevier eBooks · doi:10.1016/b978-032304841-5.50055-8 · Cited by 6 · see citing works
Antifungal Resistance: Cellular and Molecular Mechanisms
Araújo, R., & Espinel‐Ingroff, A. (2010) · Springer eBooks · doi:10.1007/978-3-642-12173-9_7 · Cited by 5 · see citing works
Bendel, C. M. (2006) · Elsevier eBooks · doi:10.1016/b0-72-160537-0/50035-9 · Cited by 4 · see citing works
Mucocutaneous and Deeply Invasive Candidiasis
Shoham, S., Nucci, M., & Walsh, T. J. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3935-5.00088-4 · Cited by 4 · see citing works
Resistance to Antifungal Drugs
Sanglard, D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6640-7_9 · Cited by 3 · see citing works
Antifungal Drug Resistance in Developing Countries
Perlin, D. S. (2009) · Springer eBooks · doi:10.1007/978-0-387-89370-9_9 · Cited by 4 · see citing works
Acute Pyelonephritis and Candidemia Due to Candida lusitaniae : A Case Report
Tsuboi, M., Uno, S., Hase, R., Yano, Y., Sando, E., Otsuka, Y., & Hosokawa, N. (2016) · Kansenshogaku zasshi · doi:10.11150/kansenshogakuzasshi.90.134 · Cited by 3 · see citing works
Bruno, D. D. C. F., Bartelli, T. F., Rodrigues, C. R., & Briones, M. R. S. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/168500 · Cited by 2 · see citing works
Clinical Evaluation of Albicans ID
Hinson, E., Tholcken, C. A., & Woods, G. L. (1997) · Laboratory Medicine · doi:10.1093/labmed/28.3.208 · Cited by 1 · see citing works
Caldas, C. D. C. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.6.2018.tde-10102017-135641
Neto, O. M. D. S., Souto, I. C. C., Rodrigues, R. C. S., & Antunes, R. P. D. A. (2021) · Odontología Sanmarquina · doi:10.15381/os.v24i2.19902
- Authors
- Pfaller, M. A., Messer, S. A., & Hollis, R. J.
- Affiliations
- University of Iowa (US)
- Venue
- Diagnostic Microbiology and Infectious Disease
- Publisher
- Elsevier BV
- Published
- 1994-11
- Volume
- 20
- Issue
- 3
- Pages
- 127-133
- ISSN
- 0732-8893 (ISSN-L)
- OpenAlex
- W2089087996
- Cited by
- 86
- References
- 26
- Citations by year
- 2025: 1 · 2023: 1 · 2021: 1 · 2019: 1 · 2018: 3 · 2017: 1 · 2016: 1 · 2015: 1 · 2014: 2 · 2012: 2
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diagnostic Microbiology and Infectious Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Yeasts and Rust Fungi Studies
- Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
- Keywords
- Candida lusitaniae, antifungal susceptibility, amphotericin B resistance, nosocomial transmission, genotypic diversity, molecular typing, electrophoretic karyotyping, restriction endonuclease analysis, 5-fluorocytosine, fluconazole, itraconazole, minimum inhibitory concentration, clinical isolates
- MeSH terms
- Antifungal Agents, Candida, Candidiasis, DNA, Fungal, Drug Resistance, Microbial, Humans, Karyotyping, Microbial Sensitivity Tests, Species Specificity, Genetic Variation, Deoxyribonucleases, Type II Site-Specific, Mycological Typing Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review